Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeoGenomics

9.84
+0.01500.15%
Pre-market: 9.910.0700+0.71%04:26 EDT
Volume:1.02M
Turnover:10.09M
Market Cap:1.26B
PE:-15.83
High:10.17
Open:9.80
Low:9.75
Close:9.83
Loading ...

NeoGenomics Provides 2025 Revenue Outlook

MT Newswires Live
·
15 Jan

NeoGenomics sees FY25 revenue $735M-$745M, consensus $727.9M

TIPRANKS
·
15 Jan

NeoGenomics updates long-term financial plan

TIPRANKS
·
15 Jan

Neogenomics Inc: Long-Range Plan Reflects 12-13% Revenue Growth Annually

THOMSON REUTERS
·
15 Jan

Neogenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

THOMSON REUTERS
·
15 Jan

Neogenomics Inc Outlook FY25 Total Revenues in Range of $735 Mln to $745 Mln

THOMSON REUTERS
·
15 Jan

NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

Business Wire
·
15 Jan

NeoGenomics (NEO) Surges 9.1%: Is This an Indication of Further Gains?

Zacks
·
15 Jan

NeoGenomics management to meet with Piper Sandler

TIPRANKS
·
15 Jan

Adaptive Biotechnologies, NeoGenomics to Support Minimal Residual Disease Monitoring Options for Blood Cancer Patients

MT Newswires Live
·
14 Jan

Adaptive, NeoGenomics partner to expand access to disease monitoring

TIPRANKS
·
14 Jan

BRIEF-Adaptive Biotechnologies Corp And Neogenomics Announce Strategic Collaboration

Reuters
·
14 Jan

Adaptive Biotechnologies Corp: Specific Financial Terms of Agreement Are Not Disclosed

THOMSON REUTERS
·
14 Jan

Adaptive Biotechnologies and Neogenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

THOMSON REUTERS
·
14 Jan

Adaptive Biotechnologies Corp: Co and Neogenomics Announce Strategic Collaboration

THOMSON REUTERS
·
14 Jan

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

GlobeNewswire
·
14 Jan